Etv6 Ntrk3 | List of Frontiers open access articles

Case Report

Published on 27 Jul 2023

Larotrectinib treatment for infantile fibrosarcoma in newborns: a case report and literature review

in Cancer Molecular Targets and Therapeutics

Dandan Wang
Fanhui Zhang
Wanli Feng
Jiarong Pan
Tianming Yuan

Frontiers in Oncology

doi 10.3389/fonc.2023.1206833

3,389 views
6 citations

Case Report

Published on 18 Apr 2024

Rapid response to fifth-line brigatinib plus entrectinib in an ALK-rearranged lung adenocarcinoma with an acquired ETV6-NTRK3 fusion: a case report

in Thoracic Oncology

Dan Li
Yue Zhu
Jincheng Song
Dafu Yang
Saiqiong Cui
Xin Liu
Le Wang
Jiangyan Zhang
Evenki Pan
Zhaoxia Dai

Frontiers in Oncology

doi 10.3389/fonc.2024.1339511

2,731 views
1 citation

Case Report

Published on 28 May 2024

Clinicopathological features of two cases of ETV6-NTRK3 rearranged papillary thyroid carcinoma: a case report

in Head and Neck Cancer

Jing Ke
Minghua Cao
Wenzhong Zhang
Hua Huang
Ping Chen
Jinhua Liu
Dan Shan
Jie Ke
Zerui Wang
Junchen Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1332522

4,123 views

Case Report

Published on 10 Jan 2023

Case report: Acquired neurotrophic tyrosine receptor kinase inhibitor resistance in a patient with pancreatic neuroendocrine carcinoma receiving entrectinib

in Cancer Molecular Targets and Therapeutics

Wen-Chi Wu
Ming-Huang Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.1031396

3,068 views
1 citation

Case Report

Published on 28 Apr 2023

Case Report: Identification of a novel NTRK3-AJUBA fusion co-existing with ETV6-NTRK3 fusion in papillary thyroid carcinoma

in Head and Neck Cancer

Qing-Xiang Yu
Wen-Jun Zhao
He-Yue Wang
Lei Zhang
Lan Qin
Lei Zhang
Jian-li Han

Frontiers in Oncology

doi 10.3389/fonc.2023.1123812

3,634 views
2 citations

Case Report

Published on 04 Aug 2023

Case Report: A case of complete response to entrectinib in NTRK fusion gene-positive parotid gland cancer

in Head and Neck Cancer

Etsuko Moriyama
Sachiko Nagasu
Toshimitsu Tanaka
Yasutaka Shimotsuura
Takeharu Ono
Hirohito Umeno
Jun Akiba
Akihiko Kawahara
Fumihiko Fujita
Takumi Kawaguchi

Frontiers in Oncology

doi 10.3389/fonc.2023.1247435

4,075 views
7 citations

Review

Published on 22 Oct 2020

Salivary Gland Carcinoma: Novel Targets to Overcome Treatment Resistance in Advanced Disease

in Head and Neck Cancer

Larissa Di Villeneuve
Ive Lima Souza
Fernanda Davila Sampaio Tolentino
Renata Ferrarotto
Gustavo Schvartsman

Frontiers in Oncology

doi 10.3389/fonc.2020.580141

26,339 views
95 citations

Original Research

Published on 28 Sep 2021

Profiling Receptor Tyrosine Kinase Fusions in Chinese Breast Cancers

in Cancer Genetics

Zhonghua Tao
Jianxia Liu
Ting Li
Hong Xu
Kai Chen
Jian Zhang
Hao Zhou
Jie Sun
Jinming Han
Zhaoji Guo

Frontiers in Oncology

doi 10.3389/fonc.2021.741142

5,606 views
8 citations

Articles

Larotrectinib treatment for infantile fibrosarcoma in newborns: a case report and literature review

Rapid response to fifth-line brigatinib plus entrectinib in an ALK-rearranged lung adenocarcinoma with an acquired ETV6-NTRK3 fusion: a case report

Clinicopathological features of two cases of ETV6-NTRK3 rearranged papillary thyroid carcinoma: a case report

Case report: Acquired neurotrophic tyrosine receptor kinase inhibitor resistance in a patient with pancreatic neuroendocrine carcinoma receiving entrectinib

Case Report: Identification of a novel NTRK3-AJUBA fusion co-existing with ETV6-NTRK3 fusion in papillary thyroid carcinoma

Case Report: A case of complete response to entrectinib in NTRK fusion gene-positive parotid gland cancer

Salivary Gland Carcinoma: Novel Targets to Overcome Treatment Resistance in Advanced Disease

Profiling Receptor Tyrosine Kinase Fusions in Chinese Breast Cancers